NASDAQ: SCPH
Scpharmaceuticals Inc Stock Ownership - Who owns Scpharmaceuticals?

Insider buying vs selling

Have Scpharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Rachael NokesCFO and Treasurer2025-01-035,235$3.56
$18.63kSell
John H. TuckerPresident and CEO2025-01-0313,360$3.56
$47.55kSell

1 of 1

SCPH insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SCPH insiders and whales buy or sell their stock.

SCPH Shareholders

What type of owners hold Scpharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC11.48%6,059,528$34.12MInstitution
Rubric Capital Management LP8.72%4,601,977$25.91MInstitution
Aigh Capital Management LLC7.33%3,867,523$21.77MInstitution
Andrew J. Schwab7.26%3,831,474$21.57MInsider
King Luther Capital Management Corp6.71%3,541,170$19.94MInstitution
Mette Kirstine Agger6.03%3,183,986$17.93MInsider
Invest A. Lundbeckfond6.03%3,183,986$17.93MInsider
5am Partners IV LLC5.43%2,864,987$16.13MInsider
Ra Capital Management LP5.17%2,727,446$15.36MInsider
Jonathan Silverstein4.88%2,576,532$14.51MInsider

1 of 3

SCPH vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SCPH63.32%36.68%Net Selling
GLUE34.03%65.97%Net Selling
MREO12.39%4.19%
FHTX72.47%14.12%Net Buying
ENGN68.02%31.98%Net Buying

Scpharmaceuticals Stock Ownership FAQ

Who owns Scpharmaceuticals?

Scpharmaceuticals (NASDAQ: SCPH) is owned by 72.35% institutional shareholders, 41.91% Scpharmaceuticals insiders, and 0.00% retail investors. Andrew J. Schwab is the largest individual Scpharmaceuticals shareholder, owning 3.83M shares representing 7.26% of the company. Andrew J. Schwab's Scpharmaceuticals shares are currently valued at $21.57M.

If you're new to stock investing, here's how to buy Scpharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.